-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Elicio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $350K, a 25.4% increase year-over-year.
- Elicio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.35M, a 43.9% increase year-over-year.
- Elicio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.18M, a 104% increase from 2022.
- Elicio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $579K, a 95.2% decline from 2021.
- Elicio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12M, a 155% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)